Omega-3 Fatty Acid
Showing 1 - 25 of >10,000
Autism Spectrum Disorder Trial in Dhaka (Omega 3 fatty acid, Placebo of Omega-3 fatty acid softgel capsule)
Recruiting
- Autism Spectrum Disorder
- Omega 3 fatty acid
- Placebo of Omega-3 fatty acid softgel capsule
-
Dhaka, BangladeshBSMMU
Nov 5, 2023
Strength, Body Composition, Muscle Soreness Trial in Waco (Omega-3 fatty acid, Placebo)
Completed
- Strength
- +2 more
- Omega-3 fatty acid
- Placebo
-
Waco, TexasBaylor University
Jun 20, 2023
Skeletal Muscle Fatty Acid Metabolism Trial in Kingston (Fish oil)
Not yet recruiting
- Skeletal Muscle Fatty Acid Metabolism
- Fish oil
-
Kingston, Ontario, CanadaSchool of Kinesiology and Health Studies
Aug 1, 2023
Healthy Aging, Ageing Well Trial in Stavanger (AvailOm, Placebo)
Not yet recruiting
- Healthy Aging
- Ageing Well
- AvailOm
- Placebo
-
Stavanger, NorwayStavanger Universitetssjukehus
Nov 20, 2023
LDL Hyperlipoproteinemia, Low-Density-Lipoprotein-Type [LDL] Hyperlipoproteinemia, Triglyceride Storage Type I or II Disease
Not yet recruiting
- LDL Hyperlipoproteinemia
- +2 more
- omega-3 fatty acids
- Placebo
-
Novosibirsk, Novosibisk Region, Russian FederationCenter of New Medical Technologies
Nov 30, 2023
Dry Eye Syndromes, Celiac Disease Trial in Tuzla (Omega-3 Fatty ACids, Control)
Recruiting
- Dry Eye Syndromes
- Celiac Disease
- Omega-3 Fatty ACids
- Control
-
Tuzla, Bosnia and HerzegovinaPlava Medical Group
Apr 11, 2023
Nutrition, Healthy Trial (Milk Protein Isolate (MPI), Soy Protein Isolate (SPI))
Not yet recruiting
- Nutrition, Healthy
- Milk Protein Isolate (MPI)
- Soy Protein Isolate (SPI)
- (no location specified)
Apr 18, 2023
Coronary Artery Disease Trial in Ankara (Omega-3 fatty acid supplementation)
Completed
- Coronary Artery Disease
- Omega-3 fatty acid supplementation
-
Ankara, TurkeyGazi University Training and Research Hospital
Dec 14, 2022
Cold Exposure Trial (Fish Oil, Placebo)
Not yet recruiting
- Cold Exposure
- Fish Oil
- Placebo
- (no location specified)
Apr 7, 2023
Absorption, Pharmacokinetics Trial in Esslingen (PL+ omega 3 fatty acids, FO EE fatty acids)
Active, not recruiting
- Absorption
- Pharmacokinetics
- PL+ omega 3 fatty acids
- FO EE fatty acids
-
Esslingen, GermanyBioTeSys GmbH
Jan 31, 2023
Migraine, Omega-3 Polyunsaturated Fatty Acids Trial in Taichung (Omega-3 polyunsaturated fatty acids, omega-6 PUFAs)
Completed
- Migraine
- Omega-3 Polyunsaturated Fatty Acids
- Omega-3 polyunsaturated fatty acids
- omega-6 PUFAs
-
Taichung, TaiwanKuang Tien General Hospital
Jun 22, 2022
Obesity Trial in Potchefstroom (Omega-3 long chain polyunsaturated fatty acids (n-3 LCPUFA))
Recruiting
- Obesity
- Omega-3 long chain polyunsaturated fatty acids (n-3 LCPUFA)
-
Potchefstroom, South AfricaCentre of Excellence for Nutrition, North-West University
Oct 25, 2022
Breast Cancer, Ovarian Tumor, Pain Trial in Albuquerque (Omega-3 fatty acid, Placebo, Paclitaxel)
Completed
- Breast Cancer
- +2 more
- Omega-3 fatty acid
- +2 more
-
Albuquerque, New Mexico
- +1 more
Oct 4, 2022
MDD, Overweight, Inflammation Trial in Atlanta, Boston (Placebo, EPA 1 g/day, EPA 2 g/day)
Completed
- Major Depressive Disorder
- +2 more
- Placebo
- +3 more
-
Atlanta, Georgia
- +1 more
Apr 4, 2022
Colorectal Cancer, Lynch Syndrome Trial in Kansas City (Omega-3 fatty acid ethyl esters (2 gram))
Active, not recruiting
- Colorectal Cancer
- Lynch Syndrome
- Omega-3 fatty acid ethyl esters (2 gram)
-
Kansas City, KansasThe University of Kansas Cancer Center, Westwood Campus
Nov 7, 2022
Granular Capsule Formulation of Omega-3 Fatty Acid Ethyl Esters:
Completed
- Hyperlipidemia
- Omega-3 fatty acid ethyl esters
- Standard antihyperlipidemic therapy other than administration of omega-3 fatty acid ethyl esters (Lotriga).
-
Osaka, Japan
- +1 more
Dec 2, 2021
Age-Related Macular Degeneration Trial in Shanghai (Krill Oil 500 MG, Olive Oil 500MG)
Not yet recruiting
- Age-Related Macular Degeneration
- Krill Oil 500 MG
- Olive Oil 500MG
-
Shanghai, ChinaShanghai General Hospital, Shanghai Jiao Tong University
Jul 15, 2022
TBI Trial in Philadelphia (Omega 3 fatty acid, Safflower seed oil)
Withdrawn
- TBI
- Omega 3 fatty acid
- Safflower seed oil
-
Philadelphia, PennsylvaniaPenn Presbyterian Medical Center
Oct 10, 2022
Colon Cancer Trial in Boston (AMR101 (VASCEPA, icosapent ethyl))
Withdrawn
- Colon Cancer
- AMR101 (VASCEPA, icosapent ethyl)
-
Boston, MassachusettsMassachusetts General Hospital
Nov 10, 2021
Chronic Venous Leg Ulcers Trial in Columbus (EPA+DHA, )
Recruiting
- Chronic Venous Leg Ulcers
- EPA+DHA
- placebo
-
Columbus, OhioThe Ohio State University College of Nursing
Mar 29, 2022
Diabetes, Type 1, Hypoglycemia, Diabetes Trial in Miami (Cholecalciferol, Omega 3 fatty acid)
Recruiting
- Diabetes Mellitus, Type 1
- +3 more
- Cholecalciferol
- Omega 3 fatty acid
-
Miami, FloridaDiabetes Research Institute, University of Miami Miller School o
Aug 9, 2022
Cognition, Insulin Resistance and Omega-3 Fatty Acid Biomarkers
Recruiting
- Breast Cancer
- Obesity
-
Columbus, OhioThe Ohio State University
Feb 15, 2022
Sjogren's Syndrome Trial in Erbil (Omega 3 fatty acid, Placebo)
Recruiting
- Sjogren's Syndrome
- Omega 3 fatty acid
- Placebo
-
Erbil, IraqReumatology out patient clinic,
Apr 22, 2022
Attention Deficit Disorder Trial in Cincinnati (DHA Omega-3, Placebo)
Completed
- Attention Deficit Disorder
- DHA Omega-3
- Placebo
-
Cincinnati, OhioUniversity of Cincinnati, Department of Psychiatry and Behaviora
Feb 21, 2022
Kidney Transplantation Trial in Norway (Omacor, Placebo Oral Capsule)
Active, not recruiting
- Kidney Transplantation
- Omacor
- Placebo Oral Capsule
-
Lørenskog, Akershus, Norway
- +5 more
Oct 18, 2022